medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2019, Number 11

<< Back Next >>

Ginecol Obstet Mex 2019; 87 (11)

Churg-Strauss syndrome and pregnancy. Case report and bibliographic review

Piñel-Pérez CS, Gómez-Roso JMJ, López-Galián JJ

Language: Spanish
References: 30
Page: 756-761
PDF size: 300.13 Kb.


ABSTRACT

Background: Churg-Strauss syndrome is an ANCA-associated vasculitis that mainly affects small vessels. Asthma, fever, eosinophilia and small vessel vasculitis are the main clinical characteristics. The most commonly observed complication is preterm delivery. Other complications are fetal loss, fetal growth restriction and more often cesarean delivery.
Clinic case: A 38-year-old woman, first pregnancy, with previous diagnosis of Churg-Strauss Syndrome. Woman is in remission for 4 years, maintaining treatment with glucocorticoid. Pregnancy advance without complications, with normal laboratory data (negative ANCA), without severe asthmatic crisis. She only refers to episodes of mild bronchial asthma and well controlled with described medication and allergic rhinitis. Ultrasound identifies low fetal weight, without signals of fetal growth restriction. A cesarean section was performed at 38+6 weeks of pregnancy for breech presentation, after failure of external cephalic version. Neonate has a 15th percentile of weight, an APGAR of 10/10 and a umbilical artery pH of 7.27. Newborn does not require reanimation or NICU admission. Puerperium was normal.
Conclusions: Diagnosis prior to pregnancy is very important for the prognosis of pregnancy. It allows to choose the perfect moment for pregnancy start (remission, absence of mother organic complications, negative antibodies) and to control and reduce the complications occurrence.


REFERENCES

  1. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997; 337: 1512-23. doi: 10.1056/NEJM199711203372106

  2. Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies. Lancet. 2006; 368: 404-18. doi: 10.1016/ S0140-6736(06)69114-9

  3. Sablé-Fourtassou R, et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med. 2005; 143: 632-8. doi: 10.7326/0003-4819-143-9- 200511010-00006

  4. Mestre J, et al. Vasculitis de pequeño vaso. Vasculitis necrotizantes: panarteritis nodosa y vasculitis ANCA asociadas. Enfermedad de Kawasaki. Medicine. 2017; 12 (29): 1704- 15. doi: 10.1016/j.med.2017.03.003

  5. Jones R, et al. Rituximab vs cyclophosphamide in ANCAassociated renal vasculitis. N Engl J Med. 2010; 363: 211-20. doi: 10.1056/NEJMoa0909169

  6. Stone JH, et al. Rituximab vs cyclophosphamide for ANCAassociated renal vasculitis. N Engl J Med. 2010; 363: 221-32. doi: 10.1056/NEJMoa0909905

  7. Yates M, et al. EULAR/ ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016; 75 (9): 1583-94. doi: http://dx.doi.org/10.1136/ annrheumdis-2016-209133

  8. Machen L, Clowse M. Vasculitis and Pregnancy. Rheum Dis Clin N Am. 2017; 43 (2): 239-247. doi: 10.1016/j.rdc.2016.12.005

  9. Singh P, et al. Successful treatment outcomes in pregnant patients with ANCA-associated vasculitis: A systematic review of literature. Int J Rheum Dis. 2018; 21: 1734–1740. doi: 10.1111/1756-185X.13342

  10. Doria A, et al. Pre-pregnancy counselling of patients with vasculitis. 2008. Rheumatology. 2008;47: Suppl 3: iii13-5. doi: 10.1093/rheumatology/ken152

  11. Croft A, et al. Successful outcome of pregnancy in patients with anti-neutrophil cytoplasm antibody-associated small vessel vasculitis. Kidney Int. 2015; 87 (4): 807-11. doi: 10.1038/ki.2014.329

  12. Gardosi J, et al. An adjustable fetal weight standard. Ultrasound Obstet Gynecol. 1995 Sep; 6 (3): 168-74. doi: 10.1046/j.1469-0705.1995.06030168.x

  13. Figueras F, et al. Customized birthweight standards for a Spanish population. Eur J Obstet Gynecol Reprod Biol. 2008 Jan; 136 (1): 20-4. doi: 10.1016/j.ejogrb.2006.12.015

  14. Seo P. Pregnancy and vasculitis. Rheum Dis Clin N Am. 2007; 33: 299-17. doi: http://dx.doi.org/10.3265/Nefrologia. pre2013.Apr.11914

  15. Pagnoux C. Grossesse et vascularites. Presse Med. 2008; 37:1657-1665. doi: 10.1016/j.lpm.2008.08.005

  16. Lima F, et al. Pregnancy in granulomatous vasculitis. Ann Rheum Dis. 1995; 54: 604-6. doi: 10.1136/ard.2005.037598

  17. Metha A, et al. A 39-year-old postpartum woman with foot drop and shortness of breath. Chest. 2016; 149 (2): e61-e64. doi: 10.1016/j.chest.2015.10.051

  18. Diamanti L, et al. Spinal hemorrhage in eosinophilic granulomatosis with polyangitis (Churg-Strauss). J Neurol. 2014; 261:438-40. doi: 10.1007/s00415-013-7217-3

  19. Corradi D, et al. Postpartum Churg-Strauss síndrome with severe cardiac involvement: description of a case and review of the literature. Clin Rheumatol. 2009; 28: 739-43. doi: https:// link.springer.com/article/10.1007/s10067-009-1143-x

  20. Hiyama J, et al. Churg-Strauss Syndrome associated with pregnancy. Intern Med. 2000; 39 (11): 985-90. doi: 10.2169/internalmedicine.39.985

  21. Ogasawara M, et al. Succesful pregnancy in a Churg-Strauss Syndrome patient with a history of intrauterine fetal death. Int Arch Allergy Immunol. 1995; 108: 200-2. doi: 10.1159/000237140

  22. Priori R, et al. Churg-Strauss syndrome during pregnancy after steroid withdrawal. The Lancet. 1998; 352: 1599- 1600. doi: 10.1016/s0140-6736(05)61046-x

  23. Barry C, et al. Churg-Strauss disease: deterioration in a twin pregnancy. Successful outcome following treatment with corticosteroids and cyclophosphamide. BJOG. 1997. 104; 746- 747. doi: https://doi.org/10.1111/j.1471-0528.1997.tb11991.x

  24. Connolly JO, et al. Fulminant pregnancy-related Churg- Strauss Syndrome. Br J Rheumatol. 1994; 33 (8): 776-7. doi: https://doi.org/10.1093/rheumatology/33.8.776

  25. Cormio G, et al. Successful pregnancy in a patient with Churg-Strauss syndrome. Eur J Obstet Gynecol Repod Biol. 1995; 60(1):81-83. doi: https://doi.org/10.1016/0028- 2243(94)02032-9

  26. Debby A, Taet al. Allergic granulomatosis and angiitis (Churg-Strauss vasculitis) in pregnancy. Int Arch Allergy Immunol 1993; 102: 307-8. doi: https://doi. org/10.1159/000236543

  27. Vega J, Méndez GP. Evolución de una vasculitis renal asociada a anticuerpos anti-citoplasma de neutrófilos (ANCA) durante un embarazo. Caso clínico. Rv. Méd. Chile 2016; 144 (10): 1351-55. doi: https://scielo.conicyt.cl/pdf/rmc/ v144n10/art16.pdf

  28. Branch DW. Physiologic adaptations of pregnancy. AmJ Reprod Immunol 1992; 28:120-2. doi: https://doi. org/10.1111/j.1600-0897.1992.tb00771.x

  29. Belo L, et al. Fluctuations in C-reactive protein concentration and neutrophil activation during normal human pregnancy. Eur J Obstet Gynecol Reprod Biol 2005; 123: 46-51. doi: 10.1016/j.ejogrb.2005.02.022

  30. Hot A, et al. Marked improvement of Churg‐Strauss vasculitis with intravenous gamma globulins during pregnancy. Clin Rheumatol. 2007; 26: 2149‐51. doi: 10.1007/s10067- 007-0628-8




2020     |     www.medigraphic.com